Coreceptor Usage of Human Immunodeficiency Virus Type 1 Strains in Ibadan, Nigeria
Journal Title: International STD Research & Reviews - Year 2015, Vol 3, Issue 2
Abstract
Aims: To evaluate HIV-1 Coreceptor usage in Nigeria. Study Design: Cross-sectional study. Place and Duration of Study: Department of Virology, College of Medicine, University College Hospital, Ibadan from January 2004 to December 2006. Methodology: Genomic DNA was extracted from blood samples of 85 (42 males, 43 females; age range 18-58 years) consenting HIV-1 infected antiretroviral therapy-naïve individuals presenting at a voluntary counseling and testing centre. The env C2-V3 region of HIV-1 proviral DNA was amplified by nested PCR, successfully sequenced, manually edited and evolutionary relationships determined by maximum likelihood using MEGA 5.03R from 64 of the blood samples of the HIV-1 infected patients. HIV-1 coreceptor usage was predicted based on genotypic analysis of HIV-1 env V3 loop sequences. Results: Phylogenetic analysis showed HIV-1 subtypes A, G, CRF02_AG, CRF06_cpx, and CRF35_AD among the study participants The V3 loop region of the viruseshad amino acid sequence conservation in the base positions 1-8 and 26-35 and tip regions and sequence variability, including mutations and deletions at positions 9-25. Most (76.6%) of the sequences had the GPGQ crown motif while the GPGQ/L/R/K substitution was observed in 18.8%. The number of N-linked glycosylation sites ranged from 0 to 4 per env C2-V3 amino acid sequence with only 37.5% of the sequences having all 4 N-linked glycosylation sites. Predicted frequencies for CCR5 and CXCR4 genotypes were 31.2% and 68.8%, respectively, while 10% of the CCR5-tropic viruses showed Maraviroc-associated resistant mutations. Conclusion: CXCR4-tropic viruses predominate among the studied population irrespective of HIV-1 subtype and and it is associated with multiple amino acid deletions and mutations in V3 and the loss of one or more N-linked glycosylation sites. This data suggest the need for further studies involving a larger sample size prior to introduction of coreceptor inhibitors like Maraviroc for management of HIV infection in Nigeria.
Authors and Affiliations
D. O. Olaleye, E. Donbraye, G. N. Odaibo
Keywords
Related Articles
- EP ID EP242826
- DOI 10.9734/ISRR/2015/16131
- Views 129
- Downloads 0
Scaling Up Community ART Groups in Mozambique
Aims: To describe the stepwise implementation and roll out of Community ART Groups (CAG) in Mozambique. Study Design: Descriptive study Place and Duration of Study: Mozambique, between February 2008 and December 2011. Me...
Risky Sexual Behaviour among University Students
Introduction: Early sexual debut, having multiple sex partners, and non-use of condoms are some of the risky sexual behaviors among young people that makes them vulnerable to many health problems such as sexually transmi...
Knowledge and Practices Regarding Prevention of Mother-to-child Transmission of HIV among Health Workers in Primary Healthcare Centers in Sokoto, Nigeria
Introduction: Evidence from studies has shown that transmission of HIV from mother-to-child during pregnancy, labor, delivery or breastfeeding can be reduced from 15 – 45% in the absence of any intervention to below 5% w...
Knowledge and Attitude of Health Care Workers towards Hepatitis B Infection and Vaccination in a Federal Teaching Hospital in South Western Nigeria
This study was carried out to determine the knowledge and attitude of health care workers in a Federal Teaching Hospital in South West, Nigeria towards Hepatitis B vaccination and infection. This study employed a quantit...
Foreign Aid Initiatives and the HIV/AIDS Epidemic in Nigeria: Perspectives on Country Ownership and Humanistic Care
With a prevalence rate of 3.1%, Nigeria has a generalized HIV/AIDS epidemic. Like much other developing countries, Nigeria has to collaborate with development partners to fight the HIV/AIDS scourge. This review assesses...